Conditions: Rheumatoid Arthritis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 106
Healthy volunteers: no

Brief summary:
This study will look at whether this new drug is effective in the treatment of rheumatoid arthritis, and at whether it is safe and well-tolerated by participants with the disease.

Detailed description:

Arms:
arm 1: MK-0873 1.25 mg twice daily for 12 weeks arm 2: Matching placebo to MK-0873 1.25 mg twice daily for 12 weeks

Interventions: intervention 1: MK-0873 intervention 2: Comparator: Placebo
Intervention descriptions: intervention 1: MK-0873 1.25 mg twice daily for 12 weeks intervention 2: Matching placebo to MK-0873 1.25 mg twice daily for 12 weeks

Protocol document: